Please login to read the full article.
Scrip Regulatory Affairs
China tightens oversight of contract manufacturers and traders
08 August 2011
Wang Fangqing
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Immediate improvements sought in EU-wide surveillance of medical devices
- New EU anti-counterfeiting rules: comprehensive but costly
- Delay in China's review time for drugs likely to continue; review predictability and transparency improve
- Brand vs generic: the battle rages over EU anti-counterfeit 'safety features'
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
